BAFETINIB-P1-GBM-01: A Pilot Study Using Intracerebral Microdialysis to Determine the Neuropharmacokinetics of Bafetinib in Patients With Recurrent Brain Tumors.
Phase of Trial: Phase I
Latest Information Update: 19 Apr 2018
At a glance
- Drugs Bafetinib (Primary)
- Indications Brain metastases; Glioblastoma
- Focus Pharmacokinetics; Therapeutic Use
- 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 04 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Feb 2011 CytRx Corporation added as company association